Research!America

​During a dedication ceremony for the new Paul G. Rogers conference room at Research!America’s new office on December 8, many fellow research advocates, friends and family members paid tribute to the former Research!America chair, describing his tremendous support and unshakeable dedication to health research. “He made a difference in my life in a way that few people have,” said Research!America president and CEO Mary Woolley. “I treasure his memory every day.” Rogers was elected to Congress in 1955 and served until 1979. During his time as a Florida representative, he rose through the ranks to chair the House Subcommittee on Health and the Environment. His long list of legislative...
Nine years ago, Rebecca went to the emergency room with appendicitis-like pains. CT scans revealed that she had a tumor the size of a grapefruit sitting on her ovary. She was diagnosed with late-stage ovarian cancer, which has a five-year survival rate of 39 percent. “It was like a big baseball bat to the stomach when you find out you have cancer. The fear of the unknown is intense,” recalls Rebecca. “You think, is life over.” Finding a trial After receiving her diagnosis, Rebecca had surgery and chemotherapy, yet cancer cells remained in her body. Up to that point, Rebecca had heard of clinical trials but didn’t know much about them. Based on her doctor’s recommendation, she decided to...
Each blockbuster drug, every novel vaccine or innovative therapy now heralded as a lifesaving miracle had the humblest of beginnings – as a project in a scientist’s lab. Through years of study and millions of dollars invested, these discoveries became the groundbreaking treatments that changed people’s lives. A scientist’s idea and a medicine’s path to patients who need it is one of the best stories out there, and we at Spectrum get to tell it every day. Spectrum is a proud member of Research!America. We are a public relations firm serving clients exclusively in health, medicine and life science, and we share Research!America’s passion for medical research and the promise of scientific...
Dear Research Advocate: Research!America yesterday released our recommendations for the top five science priorities the new Congress should address in its first 100 days: end sequestration, increase funding for our nation’€™s research agencies, advance the 21st Century Cures Initiative legislation, repeal the medical device tax, and enact a permanent and enhanced R&D tax credit. See the full press release here . Among these priorities, ending sequestration is the steepest uphill climb – but what a difference it would make for the future of health and the nation’s economy! That’€™s the focus of this editable message to members of Congress. Please weigh in! Securing meaningful increases...
Letter to the editor by Research!America VP of Communications Suzanne Ffolkes published in The Gainesville Sun . In reference to the Dec. 28 editorial ’€œ Funding innovation ,’€ countless medical breakthroughs would not have been possible without the support of federal funding. It is imperative that research and innovation become a higher national priority for the new Congress. Bipartisan proposals to advance medical progress ’€” like the 21st Century Cures Initiative that includes provisions to boost federal funding for research, modernize clinical trials and incentivize the development of new drugs and devices, among others ’€” should be given serious consideration. Stagnant funding over...
In honor of #GivingTuesday , Jayme and Julie talk about their experience working at Research!America to help boost federal support for medical research and innovation. Jayme Hennenfent , D.V.M., M.S. I was honored to embark on a science policy fellowship at Research!America because I know firsthand how crucial funding is to the discovery process. My alma mater, The University of Illinois at Urbana-Champaign, is a preeminent research institution, spending over a half a billion dollars on science and technology research annually. However, even powerhouses like this are not immune to the current struggle for project funding support, which I personally observed when I saw world-class...
Dear Research Advocate: Mark your calendar for two important days next week: First, next Monday, Dec. 1, is World AIDS Day. Check out our updated fact sheet , which provides a snapshot of HIV/AIDS and the transformative impact of HIV/AIDS research. I especially hope that you will take the time to read the profile of Maria Davis, an individual living with HIV who works to help others with, or at risk of contracting, the disease. When I think of what I’€™m thankful for, people like Maria are high on my list. Which leads me to another reason to express gratitude, this time to the many organizations and individuals who participated in Public Health Thank You Day (PHTYD) on Nov. 24. Research!...
Public Health Thank You Day, November 24, 2014 ALEXANDRIA, Va.-November 20, 2014 -As Thanksgiving approaches, Research!America and leading U.S. public health organizations urge Americans to salute public health professionals who go above and beyond to protect the health of our nation. Public Health Thank You Day honors all those unsung heroes who keep our drinking water safe and air clean, develop vaccines, track and investigate infections, and protect us against threats such as influenza, the Ebola and Enterovirus D68 outbreaks and natural disasters. “Every day, public health professionals here and around the world work in challenging and sometimes dangerous situations to protect our...
November 18, 2014 We extend warmest congratulations to Congressman Rush D. Holt, Ph.D., on the announcement of his new position as chief executive officer of The American Association for the Advancement of Science (AAAS) and executive publisher of Science family of journals. As a trained physicist, Representative Holt leveraged his scientific understanding to propel and enact policies that have contributed significantly to improving our nation’s health and economic security. During his distinguished tenure in Congress, he worked tirelessly to lift the ban on federal funding for embryonic stem cell research and helped enact the America COMPETES Act to strengthen investments in research and...
November 5, 2014 Fighting Ebola and other infectious disease threats is a rightful and critical facet of our national defense. As Congress considers the President’s comprehensive emergency funding request for Ebola, we urge members of Congress to respond on a bipartisan basis. Americans expect our nation’s leaders to present a unified front against national threats, allocating the funding needed to protect our nation. We also expect common sense, which means treating an emergency as an emergency and refraining from haphazardly cutting funding for other priorities in order to “pay for” protecting the American public. Sustained investments in research are necessary to enhance our capability...

Pages

Sidebar Quote

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco